News
Risks to BMY include potential for tariffs to raise costs of drugs manufactured outside of the U.S. Moreover, drug pricing ...
Shares of clinical-stage company Summit Therapeutics SMMT rose nearly 9% on Thursday following a report issued by Bloomberg, ...
3h
Zacks Investment Research on MSNHow to Maximize Your Retirement Portfolio with These Top-Ranked Dividend StocksHere's an eye-opening statistic: older Americans are more afraid of running out of money than of death itself. And older Americans have legitimate reasons for this worry, even if they have dutifully ...
4h
Zacks Investment Research on MSNInvestors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to KnowBristol Myers Squibb (BMY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.
Advise pregnant women of the potential risk to a fetus. Advise females of reproductive potential to use effective non-hormonal contraception during treatment with AUGTYRO and for 2 months following ...
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions ...
Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.
Ashwin Kishtagari, MD, of Vanderbilt University Medical Center in Nashville, summarizes 7 studies presented at the EHA 2025 Congress.
Nandita Vijayasimha, Bengaluru Monday, July 7, 2025, 08:00 Hrs [IST] ...
Bristol-Myers Squibb is testing MORAb-202 in a Phase 2 trial to challenge traditional chemotherapy for platinum-resistant ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results